1. Lefvert AK. Human and experimental myasthenia gravis. In: Coutinho A, Kazatchine M, Wiley-Liss, Inc. Eds. Autoimmunity: Physiology and Disease. New York 1994; 267-305.
2. Åhlberg RE, Pirkanen R, Lefvert AK. Defective T lymphocyte function in nonthymectomized patients with myasthenia gravis. Clin. Immunol. Immunopathol. 1991; 60:93–105.
3. Dropcho EJ, Richman DP, Antel J, Arnason BGW. Defective mitogenic responses in myasthenia gravis and multiple sclerosis. Ann. Neurol. 1982; 11:456–462.
4. Zilko PJ, Dawkins RL, Holmes K, Witt C. Genetic control of suppressor lymphocyte function in myasthenia gravis: Relationship of impaired suppressor function to HLA-B8/DRW3 and cold reactive lymphocytotoxic antibodies. Clin. Immunol. Immunopathol. 1979; 14:222–230.
5. Mischak RP, Dau PC, Gonzales RL, Spitler LE. In vitro testing of suppressor cell activity in myasthenia gravis. In: Dau PC, Ed. Plasmapheresis and the Immunobiology of myasthenia gravis. Houghton, Boston, 1979.